Culture WhatsMyPot matches you with your best bud The free web service recommends your ideal strains based on a database of product descriptions and over 600 medical articles Nick LabaFebruary 5, 2020
Financing Execs shouldn’t get big payouts until companies are cash flow positive: Ryerson prof Massive bonuses and mansions drew the ire of shareholders in MedMen, which demoted its CEO on Friday Nick LabaFebruary 3, 2020
Culture Mugglehead’s monthly playlist – January ‘20 A playlist of new tracks from the month well-suited for your time spent stoned Nick LabaJanuary 31, 2020
Driving RoadSafetyBC flags chronic patient for cannabis use only after legalization Stephanie deJager says her weed use and other meds had been documented for years, but last November cannabis appeared in a letter for the... Nick LabaJanuary 28, 2020
Investment Ideas WeedMD CEO says medical cannabis shouldn’t be taxed, 2020 will be a shakeout: Q&A Learn what the executive has to say about enforcing the illicit market, and if he's ever smoked weed himself Nick LabaJanuary 24, 2020
Real Estate Innovative Industrial Properties announces public offering of 2 million shares The REIT has been notably resistant to the downturn of the cannabis market Nick LabaJanuary 23, 2020
Data Weed shoppers are spending an average of $153 in Illinois: Headset data Sales figures from one of the U.S.’s most recent recreational markets is heads above the rest Nick LabaJanuary 22, 2020
Culture Watch: Viral video of Illinois cops’ Cheech and Chong-themed PSA The Park Forest Police Department says the parody is meant to clear the smoke on some of the state's new weed laws Nick LabaJanuary 21, 2020
Medical and Pharmaceutical Cannabinol (CBN) the main ingredient in potential treatments for glaucoma and a rare skin disease InMed Pharmaceuticals has initiated a clinical trial for its epidermolysis bullosa treatment, after regulatory approval in December Nick LabaJanuary 20, 2020
Coming soon Health Canada approves two Tetra Bio Pharma topicals for over-the-counter sales Treatments for back pain and hemorrhoids will hit shelves mid-2020, company says Nick LabaJanuary 17, 2020